Enorsua, Marivic V.
HRN: 21-61-25 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2025
CEFUROXIME 1.5GM (VIAL)
05/14/2025
05/21/2025
IV
1.5g
Q8h
UTI
Waiting Final Action